Outcome court case Cryo-Save versus Salveo regarding EGM
September 6, 2013
Financial Reports
Turnaround concept “Fit for Future” concluded, implementation already started
Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, has published its financial results for the six months ended 30 June 2013.
Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces today that it has taken notice of the fact that Salveo Holding S.A. (‘Salveo’), the company’s minority shareholder with 27%, has convened an extraordinary general meeting of shareholders (‘EGM’) that shall be proposed to resolve on the appointment of a new executive director (CEO) and the replacement of one non-executive director.
Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces today that Mr Johan Goossens decided to step back from office as a Non-Executive Board Member with immediate effect.
Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces today that it has been presented with the outlines of the proposition of Salveo Holding S.A (‘Salveo’), the company’s major shareholder, underlying its request to convene an extraordinary general meeting of shareholders (‘EGM’) that shall be proposed to resolve on the appointment of a new CEO and the replacement of one non-executive director.
Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces today that following on Mr. Arnoud van Tulder’s retirement as Chief Executive Officer, effective June 1, 2013, Ms. Evi Mattil, Chief Commercial Officer, will to take over with immediate effect and on an ad interim basis the functions of Arnoud van Tulder. The search and formal procedure for the nomination of a new CEO will be started immediately.
Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces today that Mr. Arnoud van Tulder will for personal reasons retire as Chief Executive Officer, effective June 1, 2013.
Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces further to its press release dated 15 May and as a matter of update of matters regarding Salveo Holding S.A. (‘Salveo’), Cryo-Save’s new 27 % shareholder, that it has received a request by Salveo to convene an extraordinary general meeting of shareholders.
Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Company’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces that the Board of Directors has decided to appoint its Non-Executive Director Mr. Walter van Pottelberge as Chairman of the Board as of today. Mr. Van Pottelberge will replace Mr. Johan Goossens, who will remain a NonExecutive Director.
Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces that all proposed resolutions at today’s AGM were passed, except for the proposal to cancel the shares currently held in treasury.